The Cleveland Clinic Medical Innovations Summit for cardiovascular technologies has identified the Top 10 Medical Innovations for 2012, ie, the upand- coming technologies that will have the biggest impact on healthcare in 2012. Topping the list is catheter-based renal denervation to control resistant hypertension.
According to a new report by Life Science Intelligence the global market for vascular closure devices will exceed US$800 million by 2015. However, its growth will be limited by an increased use of transradial artery access and manual compression procedures.
With laser-guided motion technology on a motorised mobile gantry for predictable and precise trajectories, Wide Bore 3D for ease in 3D acquisitions, and more than 20 advanced applications available, the Discovery IGS 730 is positioned for a new era of interventional procedures. The significance of this innovation to interventional imaging has been compared to that of the invention of flat panel technology.
Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava (IVC) filters in the Journal of Vascular and Interventional Radiology. This study, which is important for individuals with IVC filters and their doctors, supports existing guidelines developed by the Society of Interventional Radiology.
On 21 November, Covidien announced a definitive agreement to acquire Barrx Medical, leader in the treatment of Barrett’s esophagus syndrome using bipolar radiofrequency (RF) ablation devices.
The Society of Interventional Radiology (SIR) released a position statement on the maintenance of credentials for image-guided interventions that lays out guidelines for the continuation of non-coronary percutaneous artery interventional procedures privileges in the hospital setting—saying that outcomes are a more important measure of quality than procedure volume alone.
Medtronic has announced the start of SYMPLICITY HTN-3, the company’s US clinical trial of the Symplicity renal denervation system for treatment-resistant hypertension. The first patient in this landmark study was enrolled at the Prairie Heart Institute at St John’s Hospital in Springfield, USA.
A study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011, Munich, Germany, shows that percutaneous cryoablation may be an alternative therapy in patients with renal tumours who are poor candidates for surgery.
BTG has expanded its commercial presence in Europe in recent months by building an expert sales force to promote the approved uses of its products in major European markets. This team has been selling BTG’s radioembolization product TheraSphere and will also sell DC Bead and Bead Block, the company’s complementary interventional oncology products.
A strong message on retaining quality but reducing cost came from Robert Kerlan, professor of Clinical Radiology and Surgery, University of California San Francisco, USA, who delivered the Dotter Lecture at SIR s annual scientific meeting in Atlanta, USA.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos